Industry › Clinical Trials

Press Releases

HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open

Mar 04, 2025 12:26 HKT/SGT

迪拜高层代表团一行参访君圣泰医药解码中国医药创新范式

Feb 27, 2025 21:01 HKT/SGT

康哲藥業（867.HK）入選標普全球《可持續發展年鑒2025》

Feb 14, 2025 12:26 HKT/SGT

康哲药业（867.HK）入选标普全球《可持续发展年鉴2025》

Feb 14, 2025 12:11 HKT/SGT

康哲藥業獲得治療輕度至中度阿爾茨海默型癡呆症狀的新藥ZUNVEYL

Jan 09, 2025 11:17 HKT/SGT

康哲药业获得治疗轻度至中度阿尔茨海默型痴呆症状的新药ZUNVEYL

Jan 09, 2025 11:09 HKT/SGT

NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1, an AI-Driven Personalized Oral Cancer Vaccine, at ESMO Immuno-Oncology Congress 2024

Dec 12, 2024 15:27 HKT/SGT

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

Dec 10, 2024 20:30 HKT/SGT

康哲藥業獲得治療痛風及高尿酸血症的1類新藥獨家商業化權利

Dec 02, 2024 20:49 HKT/SGT

HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024

Oct 25, 2024 08:57 HKT/SGT

康哲藥業：蘆可替尼乳膏（白癜風）大灣區首批處方落地

Oct 18, 2024 14:54 HKT/SGT

GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis

Sep 25, 2024 21:00 HKT/SGT

康哲藥業：磷酸蘆可替尼乳膏（白癜風）中國上市許可申請已獲受理

Sep 24, 2024 21:46 HKT/SGT

Ainos、限られた治療法しかない希少疾患シェーグレン症候群に対するVELDONAの台湾臨床試験開始計画を発表

Sep 24, 2024 18:00 JST

Ainos、治療法が限られている希少疾患であるシェーグレン症候群の治療薬VELDONAの台湾での臨床試験開始計画を発表

Sep 19, 2024 21:00 JST

君聖泰醫藥亮相香港國際生物科技論壇

Sep 17, 2024 15:00 HKT/SGT

君聖泰醫藥亮相香港國際生物科技論壇

Sep 16, 2024 14:53 HKT/SGT

君圣泰医药亮相香港国际生物科技论坛

Sep 13, 2024 18:22 HKT/SGT

EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)

Sep 11, 2024 12:00 HKT/SGT

EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱（HTD1801）在T2DM中的两项事后分析

Sep 11, 2024 11:51 HKT/SGT